The acquisition was subject to Regen having resolved and finalized a settlement with respect to all its litigation. Regen is now ready to advance its business model and pursue its acquisition by Emergent. On July 19, 2022, Regen's Bankruptcy Motion to Dismiss was approved by the US Bankruptcy Court in New Jersey. The Acquisition is expected to close on or about August 1st, 2022.
Jim Morrison, President and CEO of Regen has agreed to join Emergents Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Emergent recently executed a letter of intent to acquire Evolutionary Biologics. The acquisition is expected to close within the next three weeks.
News 
Market Data 
Discover 
